Your search returned 37 studies. (Get alerts for new studies):
- Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Conditions: Myelodysplastic Syndrome - Leukemia
1 Location available
- Stem Cell Transplant Using Peripheral and Cord Blood Stem Cells to Treat Severe Aplastic Anemia and Myelopdysplastic Syndrome
Conditions: Myelodysplastic Syndrome (MDS) - Severe Aplastic Anemia (SAA)
1 Location available
- Phase II Study of Idarubicin, Cytarabine, and Vorinostat With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
Conditions: Acute Myeloid Leukemia (AML) - Myelodysplastic Syndrome (MDS)
1 Location available
- A Phase I Study of WT1 Peptides to Induce Anti-Leukemia Immune Responses Following Autologous or Allogeneic Transplantation for AML, CML, ALL, MDS, an
Conditions: Acute Myelogenous Leukemia (AML) - Chronic Myelogenous Leukemia (CML) - Acute Lymphoblastic Leukemia (ALL) - Myelodysplastic Syndrome (MDS) - B Cell Malignancies
1 Location available
- MRI Screening for Patients With Myelodysplastic Syndrome (MDS), Who Have Received Multiple Red Blood Cell Transfusions
Conditions: Myelodysplastic Syndrome (MDS)
1 Location available
- Immunotherapy Using Lenalidomide + Bystander Vaccine in High Risk Myelodysplastic Syndrome (MDS)
Conditions: Leukemia
1 Location available
- Phase I Study of ON 01910.Na in Refractory Leukemia or Myelodysplastic Syndrome (MDS)
Conditions: Acute Myelocytic Leukemia - Acute Lymphocytic Leukemia - Chronic Myelocytic Leukemia - Chronic Lymphocytic Leukemia - Myelodysplastic Syndromes
1 Location available
- Trial of High Dose Lenalidomide in Patients With Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Trilineage Dysplasia (AML-TLD)
Conditions: Myelodysplastic Syndrome
1 Location available
- Decitabine and Clofarabine in Higher Risk Myelodysplastic Syndromes (MDS)
Conditions: Myelodysplastic Syndrome
1 Location available
- Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood
Conditions: Leukemia, Acute Myelogenous (AML) - Leukemia, Acute Lymphocytic (ALL) - Leukemia, Chronic Myelogenous (CML) - Myelodysplastic Syndrome (MDS) - Non-Hodgkin's Lymphoma (NHL)
1 Location available
- Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study
Conditions: Myelodysplastic Syndromes
5 Locations available
- Vorinostat in Combination With Azacitidine in Patients With Newly-Diagnosed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Conditions: Leukemia
1 Location available
- Study of AR-67 (DB-67) in Myelodysplastic Syndrome (MDS)
Conditions: Myelodysplastic Syndrome
1 Location available
- A Pilot Study of a Thrombopoietin-Receptor Agonist, Eltrombopag, in Patients With Low to Int-2 Risk Myelodysplastic Syndrome (MDS)
Conditions: Myelodysplastic Syndromes - Thrombocytopenia
1 Location available
- Decitabine Maintenance for Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS) Post Transplant
Conditions: Leukemia, Myeloid, Acute - Myelodysplastic Syndromes
1 Location available
- A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Conditions: Anemia
4 Locations available
- 5-Azacytidine With Lenalidomide in Patients With High Risk Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
Conditions: Leukemia
1 Location available
- Haploidentical Allogeneic Transplant w/Post Transplant Infusion of Regulatory T-cells (BMT Protocol 204)
Conditions: Leukemia - Leukemia Chronic Myelogenous Leukemia (CML) - Blood and Marrow Transplant (BMT) - Myelodysplastic Syndromes (MDS) - Lymphomas: Non-Hodgkin
1 Location available
- Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) in Combination With Azacitidine for the Treatment of Myelodysplastic Syndrome (MDS)
Conditions: Myelodysplastic Syndromes
1 Location available
- Lenalidomide and Prednisone in Low and Int-1 Myelodysplastic Syndrome (MDS) Non 5q MDS
Conditions: Myelodysplastic Syndrome - MDS
2 Locations available
- Alemtuzumab in Myelodysplastic Syndrome (MDS), Aplastic Anemia, and T-Cell Large Granular Lymphocytic Leukemia (T-GL)
Conditions: Leukemia
1 Location available
- Study of KB004 in Subjects With Hematologic Malignancies
Conditions: Acute Myeloid Leukemia (AML) - Acute Lymphocytic Leukemia (ALL) - Chronic Myelogenous Leukemia (CML) - Myelodysplastic Syndrome (MDS) - Myeloproliferative Neoplasms (MPN)
2 Locations available
- Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies
Conditions: Acute Lymphoblastic Leukemia (ALL) - Acute Myelogenous Leukemia (AML) - Myelodysplastic Syndrome (MDS) - Non-Hodgkin's Lymphoma - Hodgkin's Disease
2 Locations available
- A Study of Two Subcutaneous Regimens of SGI-110, a DNA Hypomethylating Agent, in Subjects With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Le
Conditions: MDS - CMML - AML
7 Locations available
- Omacetaxine and Low Dose Cytarabine in Older Patients With Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
Conditions: Leukemia
1 Location available
- Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With Thrombocytopenia
Conditions: Myelodysplastic Syndrome (MDS) - Thrombocytopenia
1 Location available
- Monitoring Minimal Residual Disease Following Treatment of Patients With Acute Myeloid Leukemia (AML) or High Grade Myelodysplastic Syndrome (MDS)
Conditions: Acute Myeloid Leukemia - High Grade Myelodysplastic Syndrome
3 Locations available
- Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide
Conditions: Hodgkin's Lymphoma - Leukemia - Myelodysplastic Syndrome(MDS) - Multiple Myeloma - Non Hodgkin's Lymphoma
1 Location available
- A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Conditions: Hematologic Malignancies - Acute Leukemia - Myelodysplastic Syndrome (MDS) - Specific Subtypes of Refractory Anemia (RA) or Refractory Anemia With Ringed Sideroblasts(RARS) Subtypes - Myeloproliferative Disorder (MPD) - Hodgkin's Lymphoma - Non-Hodgkin's
1 Location available
- Post T-plant Infusion of Allogeneic Cytokine Induced Killer Cells as Consolidate Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders
Conditions: Neural Tube Defects - Anemia - Leukemia, Myeloid - Bone Marrow Transplant Failure - Myelodysplastic Syndromes (MDS) - Myeloproliferative Disorders
1 Location available
- Phase 2 Study of Telintra® in Deletion 5q Myelodysplastic Syndrome
Conditions: Myelodysplastic Syndrome (MDS)
1 Location available
- Azacitidine + Lenalidomide Combo in the Elderly Previously Treated Acute Myeloid Leukemia (AML) & High-Risk Myelodysplastic Syndromes (MDS)
Conditions: Leukemia - Acute Myeloid Leukemia (AML) - Myelodysplastic Syndromes (MDS)
1 Location available
- Clofarabine Plus Low-Dose Cytarabine for Patients With Higher-Risk Myelodysplastic Syndrome (MDS)
Conditions: Leukemia - Myeloproliferative Diseases
1 Location available
- Study of (Telintra®) in Non-Del(5q) Myelodysplastic Syndrome
Conditions: Myelodysplastic Syndrome (MDS)
3 Locations available
- Improving Blood Stem Cell Collection and Transplant Procedures
Conditions: Myelodysplastic Syndrome (MDS) - Chronic Myelogenous Leukemia - Acute Lymphoblastic Leukemia - CML (Chronic Myelogenous Leukemia - CLL (Chronic Lymphocytic Leukemia) - Acute Myeloid Leukemia (AML)
1 Location available
- Study of Azacytidine Followed by GM-CSF in Patients With Myelodysplastic Syndrome (MDS)
Conditions: Leukemia
1 Location available
- Transplants With Unlicensed Preserved Cord Blood
Conditions: Myelodysplastic Syndrome (MDS) - Hematologic Neoplasms - Hematologic Diseases - Severe Aplastic Anemia
1 Location available
|